This public procurement record has 3 releases in its history.

Award

02 May 2025 at 01:00

TenderUpdate

08 Jan 2025 at 00:00

Tender

07 Jan 2025 at 00:00

Summary of the contracting process

The Common Services Agency, also known as NHS National Services Scotland (NSS), has completed a procurement process titled "NP47825 Multiple Sclerosis Medicines," aimed at supplying multiple sclerosis medicines across NHS Scotland. The process used an open procurement method categorized under goods and was conducted through an open procedure. Key locations involved are defined under the National Health Service (Scotland) Act 1978 and other related acts, covering regions such as Edinburgh. The procurement comprised two lots, which have been awarded, and contracts were signed in April 2025. This completed procurement process took place over several stages, including planned delays in the initial phases, with significant steps conducted in January 2025 and contracts signed by April 15, 2025.

This tender represents a substantial business opportunity for suppliers in the pharmaceutical industry, particularly those able to provide medications and fulfil NHS Scotland's requirements. Large-scale pharmaceutical manufacturers such as Sandoz Ltd, Merck Serono Limited, and others were successful participants, highlighting how businesses with capabilities in producing and distributing specific medical goods can grow through public sector frameworks. Companies need to demonstrate compliance with UK regulatory standards and have well-established supply chains to participate effectively. Businesses that are geared towards providing community benefits and supporting sustainability initiatives are likely to align well with NHS Scotland's procurement objectives.

How relevant is this notice?

Notice Title

NP47825 Multiple Sclerosis Medicines

Notice Description

Supply of multiple sclerosis medicines to NHS Scotland.

Lot Information

Fingolimod capsules, teriflunomide tablets, and dimethyl fumarate capsules

Supply of fingolimod capsules, teriflunomide tablets, and dimethyl fumarate capsules to NHS Scotland. The Authority has award this Lot as a single supplier Framework Agreement per product line to three (3) Framework Participants. Full details of Goods and volumes can be found within the ITT documents.

Renewal: The Framework Agreement includes the option to extend for any number of periods, up to a maximum overall period of twenty-one (21) months, upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Glatiramer acetate solution for injection pre-filled syringes, interferon beta-1a, cladribine tablets, ozanimod capsules, and natalizumab

Supply of glatiramer acetate solution for injection pre-filled syringes, interferon beta-1a, cladribine tablets, ozanimod capsules, and natalizumab to NHS Scotland. The Authority has awarded this Lot as an unranked multi supplier Framework Agreement per line to six (6) Framework Participants. Full details of Goods and volumes can be found within the ITT (Invitation to Tender) documents.

Renewal: The Framework Agreement includes the option to extend for any number of periods, up to a maximum overall period of twenty-one (21) months, upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Publication & Lifecycle

Open Contracting ID
ocds-r6ebe6-0000784629
Publication Source
Public Contracts Scotland
Latest Notice
https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=MAY529465
Current Stage
Award
All Stages
Tender, Award

Procurement Classification

Notice Type
OJEU - F3 - Contract Award Notice
Procurement Type
Framework
Procurement Category
Goods
Procurement Method
Open
Procurement Method Details
Open procedure
Tender Suitability
Not specified
Awardee Scale
Large

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products


CPV Codes

33600000 - Pharmaceutical products

Notice Value(s)

Tender Value
£51,517,832 £10M-£100M
Lots Value
£51,517,832 £10M-£100M
Awards Value
Not specified
Contracts Value
£48,571,280 £10M-£100M

Notice Dates

Publication Date
2 May 20251 years ago
Submission Deadline
7 Feb 2025Expired
Future Notice Date
Not specified
Award Date
9 Apr 20251 years ago
Contract Period
Not specified - Not specified
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Complete
Awards Status
Not Specified
Contracts Status
Active

Contracting Authority (Buyer)

Main Buyer
The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
EDINBURGH
Postcode
EH12 9EB
Postcode Area
Edinburgh
Country
Scotland

Major Region (ITL 1)
TLM Scotland
Basic Region (ITL 2)
TLM1 East Central Scotland
Small Region (ITL 3)
TLM13 City of Edinburgh
Delivery Location
TLM Scotland

Local Authority
City of Edinburgh
Electoral Ward
Drum Brae/Gyle
Westminster Constituency
Edinburgh South West

Supplier Information

Number of Suppliers
8
Supplier Names

Biogen Idec Ltd

Merck Serono Limited

Orifarm UK

Ranbaxy (UK) Ltd

STADA UK - Thornton & Ross

Sandoz Ltd

Teva UK Ltd

Viatris UK Healthcare Ltd

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

JSON Markdown

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

Loading OCDS record...